The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Control of cell cycle transcription during G1 and S phases
Bertoli, C., Skotheim, J. M., & de Bruin, R. A. M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3629 · Cited by 1,500
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494
Mechanisms of specificity in protein phosphorylation
Ubersax, J. A., & Ferrell Jr, J. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2203 · Cited by 1,451
Acute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z.-Y., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,277
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.011 · Cited by 1,213
mTOR kinase structure, mechanism and regulation
Yang, H., Rudge, D. G., Koos, J. D., Vaidialingam, B., Yang, H. J., & Pavletich, N. P. (2013) · Nature · doi:10.1038/nature12122 · Cited by 1,075
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Yang, W., Zheng, Y., Xia, Y., Ji, H., Chen, X., Guo, F., Lyssiotis, C. A., Aldape, K., Cantley, L. C., & Lu, Z. (2012) · Nature Cell Biology · doi:10.1038/ncb2629 · Cited by 918
A human peptidyl–prolyl isomerase essential for regulation of mitosis
Ping Lu, K., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 904
Targets of the cyclin-dependent kinase Cdk1
Ubersax, J. A., Woodbury, E. L., Quang, P. N., Paraz, M., Blethrow, J. D., Shah, K., Shokat, K. M., & Morgan, D. O. (2003) · Nature · doi:10.1038/nature02062 · Cited by 892
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Yaffe, M. B., Schutkowski, M., Shen, M., Zhou, X. Z., Stukenberg, P. T., Rahfeld, J.-U., Xu, J., Kuang, J., Kirschner, M. W., Fischer, G., et al. (1997) · Science · doi:10.1126/science.278.5345.1957 · Cited by 770
Self-citationThe prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721
Self-citationRanganathan, R., Lu, K. P., Hunter, T., & Noel, J. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80273-1 · Cited by 699
Self-citationProtein phosphorylation in signaling – 50 years and counting
Pawson, T., & Scott, J. D. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.04.013 · Cited by 694
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease
Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682
Self-citationFunction of WW Domains as Phosphoserine- or Phosphothreonine-Binding Modules
Lu, P.-J., Zhou, X. Z., Shen, M., & Lu, K. P. (1999) · Science · doi:10.1126/science.283.5406.1325 · Cited by 682
Self-citationProlyl cis-trans isomerization as a molecular timer
Lu, K. P., Finn, G., Lee, T. H., & Nicholson, L. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.35 · Cited by 652
Self-citationRyo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.-C., Wulf, G., Rottapel, R., Yamaoka, S., & Lu, K. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00490-8 · Cited by 637
Self-citationRegulation of Raf-1 by Direct Feedback Phosphorylation
Dougherty, M. K., Müller, J., Ritt, D. A., Zhou, M., Zhou, X. Z., Copeland, T. D., Conrads, T. P., Veenstra, T. D., Lu, K. P., & Morrison, D. K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.055 · Cited by 633
Self-citationBrown, N. R., Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (1999) · Nature Cell Biology · doi:10.1038/15674 · Cited by 546
Pin1-Dependent Prolyl Isomerization Regulates Dephosphorylation of Cdc25C and Tau Proteins
Zhou, X. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00085-x · Cited by 544
Self-citationPML targeting eradicates quiescent leukaemia-initiating cells
Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G., Ikeda, Y., Rosenblatt, J., Avigan, D. E., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07016 · Cited by 538
Wulf, G. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3459 · Cited by 528
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
de Thé, H., & Chen, Z. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2943 · Cited by 488
The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production
Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., et al. (2006) · Nature · doi:10.1038/nature04543 · Cited by 487
Self-citationRyo, A., Nakamura, M., Wulf, G., Liou, Y.-C., & Lu, K. P. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-793 · Cited by 465
Self-citationAntibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
Kondo, A., Shahpasand, K., Mannix, R., Qiu, J., Moncaster, J., Chen, C.-H., Yao, Y., Lin, Y.-M., Driver, J. A., Sun, Y., et al. (2015) · Nature · doi:10.1038/nature14658 · Cited by 445
Self-citationThe Death-Associated Protein Kinases: Structure, Function, and Beyond
Bialik, S., & Kimchi, A. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142615 · Cited by 440
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration
Liou, Y.-C., Sun, A., Ryo, A., Zhou, X. Z., Yu, Z.-X., Huang, H.-K., Uchida, T., Bronson, R., Bing, G., Li, X., et al. (2003) · Nature · doi:10.1038/nature01832 · Cited by 435
Self-citationInverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study
Driver, J. A., Beiser, A., Au, R., Kreger, B. E., Splansky, G. L., Kurth, T., Kiel, D. P., Lu, K. P., Seshadri, S., & Wolf, P. A. (2012) · BMJ · doi:10.1136/bmj.e1442 · Cited by 425
Self-citationThe prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults
Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F., Volinia, S., Ronai, Z., Blandino, G., Schneider, C., & Sal, G. D. (2002) · Nature · doi:10.1038/nature01120 · Cited by 414
Muindi, J., Frankel, Sr., Miller, W. J., Jakubowski, A., Scheinberg, D., Young, C., Dmitrovsky, E., & Warrell, R. J. (1992) · Blood · doi:10.1182/blood.v79.2.299.bloodjournal792299 · Cited by 408
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response
Zheng, H., You, H., Zhou, X. Z., Murray, S. A., Uchida, T., Wulf, G., Gu, L., Tang, X., Lu, K. P., & Xiao, Z.-X. J. (2002) · Nature · doi:10.1038/nature01116 · Cited by 383
Self-citationPrevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers
Bao, L., Kimzey, A., Sauter, G., Sowadski, J. M., Lu, K. P., & Wang, D.-G. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63731-5 · Cited by 378
Self-citationPolo-like kinases and oncogenesis
Eckerdt, F., Yuan, J., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208273 · Cited by 365
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Nasr, R., Guillemin, M.-C., Ferhi, O., Soilihi, H., Peres, L., Berthier, C., Rousselot, P., Robledo-Sarmiento, M., Lallemand-Breitenbach, V., Gourmel, B., et al. (2008) · Nature Medicine · doi:10.1038/nm.1891 · Cited by 354
Pinning down proline-directed phosphorylation signaling
Lu, K. P., Liou, Y.-C., & Zhou, X. Z. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02253-5 · Cited by 349
Self-citationShen, M., Stukenberg, P. T., Kirschner, M. W., & Lu, K. P. (1998) · Genes & Development · doi:10.1101/gad.12.5.706 · Cited by 340
Self-citationLoss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes
Liou, Y.-C., Ryo, A., Huang, H.-K., Lu, P.-J., Bronson, R., Fujimori, F., Uchida, T., Hunter, T., & Lu, K. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032404099 · Cited by 339
Self-citationProlyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins
Liou, Y.-C., Zhou, X. Z., & Lu, K. P. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.07.001 · Cited by 326
Self-citationCancer genomics: one cell at a time
Navin, N. E. (2014) · Genome Biology · doi:10.1186/s13059-014-0452-9 · Cited by 318
Selective Inactivation of Parvulin-Like Peptidyl-Prolyl cis/trans Isomerases by Juglone
Hennig, L., Christner, C., Kipping, M., Schelbert, B., Rücknagel, K. P., Grabley, S., Küllertz, G., & Fischer, G. (1998) · Biochemistry · doi:10.1021/bi973162p · Cited by 315
Muindi, J., Frankel, Sr., Miller, W. J., Jakubowski, A., Scheinberg, D., Young, C., Dmitrovsky, E., & Warrell, R. J. (1992) · Blood · doi:10.1182/blood.v79.2.299.299 · Cited by 314
A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
Girardini, J. E., Napoli, M., Piazza, S., Rustighi, A., Marotta, C., Radaelli, E., Capaci, V., Jordan, L., Quinlan, P., Thompson, A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.004 · Cited by 286
Acquired resistance to tyrosine kinase inhibitors during cancer therapy
Engelman, J. A., & Settleman, J. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.004 · Cited by 284
Wei, S., Kozono, S., Kats, L., Nechama, M., Li, W., Guarnerio, J., Luo, M., You, M.-H., Yao, Y., Kondo, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3839 · Cited by 272
Self-citationRegulation of the Transcriptional Activity of c-Fos by ERK
Monje, P., Hernández-Losa, J., Lyons, R. J., Castellone, M. D., & Gutkind, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500353200 · Cited by 271
PIN1, the cell cycle and cancer
Yeh, E. S., & Means, A. R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2107 · Cited by 267
Nakamura, K., Greenwood, A., Binder, L., Bigio, E. H., Denial, S., Nicholson, L., Zhou, X. Z., & Lu, K. P. (2012) · Cell · doi:10.1016/j.cell.2012.02.016 · Cited by 258
Self-citationPIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells
Ryo, A., Liou, Y.-C., Wulf, G., Nakamura, M., Lee, S. W., & Lu, K. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5281-5295.2002 · Cited by 253
Self-citationLu, P.-J., Zhou, X. Z., Liou, Y.-C., Noel, J. P., & Lu, K. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100228200 · Cited by 244
Self-citationPhosphorylation-specific prolyl isomerization: is there an underlying theme?
Wulf, G., Finn, G., Suizu, F., & Lu, K. P. (2005) · Nature Cell Biology · doi:10.1038/ncb0505-435 · Cited by 238
Self-citationPinning down cell signaling, cancer and Alzheimer's disease
Lu, K. P. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.02.002 · Cited by 237
Self-citationIncidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation
Stewart, T., Tsai, S.-C., Grayson, H., Henderson, R., & Opelz, G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91618-0 · Cited by 235
Wulf, G. M., Liou, Y.-C., Ryo, A., Lee, S. W., & Lu, K. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200538200 · Cited by 228
Self-citationThe prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
Ayala, G., Wang, D.-G., Wulf, G. M., Frolov, A., Li, R., Sowadski, J. M., Wheeler, T. M., Lu, K. P., & Bao, L. (2003) · PubMed · Cited by 216
Self-citationMice Lacking Pin1 Develop Normally, but Are Defective in Entering Cell Cycle from G0 Arrest
Fujimori, F., Takahashi, K., Uchida, C., & Uchida, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1736 · Cited by 215
Acute promyelocytic leukemia, arsenic, and PML bodies
de Thé, H., Le Bras, M., & Lallemand-Breitenbach, V. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201112044 · Cited by 213
BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression
MacLachlan, T. K., Somasundaram, K., Sgagias, M., Shifman, Y., Muschel, R. J., Cowan, K. H., & El-Deiry, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2777 · Cited by 212
Connolly, R. M., Nguyen, N. K., & Sukumar, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3175 · Cited by 211
Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis
Wulf, G., Garg, P., Liou, Y., Iglehart, D., & Lu, K. P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600323 · Cited by 203
Self-citationProlyl isomerase Pin1 in cancer
Lu, Z., & Hunter, T. (2014) · Cell Research · doi:10.1038/cr.2014.109 · Cited by 201
Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions
Weigel, N. L., & Moore, N. L. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0101 · Cited by 196
Yuan, W.-C., Lee, Y.-R., Huang, S.-F., Lin, Y.-M., Chen, T.-Y., Chung, H.-C., Tsai, C.-H., Chen, H.-Y., Chiang, C.-T., Lai, C.-K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.008 · Cited by 184
Self-citationLee, T. H., Chen, C.-H., Suizu, F., Huang, P., Schiene-Fischer, C., Daum, S., Zhang, Y. J., Goate, A., Chen, R.-H., Zhou, X. Z., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.005 · Cited by 183
Self-citationPeptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease
Lee, T. H., Pastorino, L., & Lu, K. P. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001906 · Cited by 181
Self-citationPin1 and Par14 Peptidyl Prolyl Isomerase Inhibitors Block Cell Proliferation
Uchida, T., Takamiya, M., Takahashi, M., Miyashita, H., Ikeda, H., Terada, T., Matsuo, Y., Shirouzu, M., Yokoyama, S., Fujimori, F., et al. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00310-1 · Cited by 174
Zheng, Y., Xia, Y., Hawke, D., Halle, M., Tremblay, M. L., Gao, X., Zhou, X. Z., Aldape, K., Cobb, M. H., Xie, K., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.013 · Cited by 172
Self-citationThe prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer
Rustighi, A., Tiberi, L., Soldano, A., Napoli, M., Nuciforo, P., Rosato, A., Kaplan, F., Capobianco, A., Pece, S., Di Fiore, P. P., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1822 · Cited by 169
Pin1 Acts Catalytically to Promote a Conformational Change in Cdc25
Stukenberg, P. T., & Kirschner, M. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00245-3 · Cited by 169
Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription
Chao, S.-H. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.3.767 · Cited by 159
Prolyl‐isomerase Pin1 controls normal and cancer stem cells of the breast
Rustighi, A., Zannini, A., Tiberi, L., Sommaggio, R., Piazza, S., Sorrentino, G., Nuzzo, S., Tuscano, A., Eterno, V., Benvenuti, F., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302909 · Cited by 158
Mantovani, F., Tocco, F., Girardini, J. E., Smith, P., Gasco, M., Lü, X., Crook, T., & Sal, G. D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1306 · Cited by 155
The structure of the cell cycle protein Cdc14 reveals a proline‐directed protein phosphatase
Gray, C. H., Good, V. M., Tonks, N. K., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg348 · Cited by 151
Phosphorylation stabilizes Nanog by promoting its interaction with Pin1
Moretto-Zita, M., Jin, H., Shen, Z., Zhao, T., Briggs, S. P., & Xu, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005847107 · Cited by 149
Min, S. H., Lau, A. W., Lee, T. H., Inuzuka, H., Wei, S., Huang, P., Shaik, S., Lee, D. Y., Finn, G., Balaštík, M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.012 · Cited by 149
Self-citationLim, B.-K., Xiong, D., Dörner, A., Youn, T., Yung, A., Liu, T., Gu, Y., Dalton, N. D., Wright, A. T., Evans, S. Μ., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34777 · Cited by 146
Farrell, A. S., Pelz, C., Wang, X., Daniel, C. J., Wang, Z., Su, Y., Janghorban, M., Zhang, X., Morgan, C. W., Impey, S., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01455-12 · Cited by 143
Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism
Zhou, X. Z., Lu, P., Wulf, G. M., & Lu, K. P. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050026 · Cited by 142
Self-citationStructural Basis for High-Affinity Peptide Inhibition of Human Pin1
Zhang, Y., Daum, S., Wildemann, D., Zhou, X. Z., Verdecia, M. A., Bowman, M. E., Lücke, C., Hunter, T. R., Lu, K.-P., Fischer, G. S., et al. (2007) · ACS Chemical Biology · doi:10.1021/cb7000044 · Cited by 141
Self-citationRamelot, T. A., & Nicholson, L. K. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4535 · Cited by 138
Pang, R. W. C., Lee, T. K., Poon, R. T. P., Fan, S. T., Wong, K., Kwong, Y., & Tse, E. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.12.030 · Cited by 137
Positive and negative regulation of granulopoiesis by endogenous RARα
Kastner, P., Lawrence, H. J., Waltzinger, C., Ghyselinck, N. B., Chambon, P., & Chan, S. H. (2001) · Blood · doi:10.1182/blood.v97.5.1314 · Cited by 135
Pin1 regulates the timing of mammalian primordial germ cell proliferation
Atchison, F. W., Capel, B., & Means, A. R. (2003) · Development · doi:10.1242/dev.00584 · Cited by 133
Arrieta, O. G., la Rosa, C. H. G.-D., Aréchaga-Ocampo, E., Villanueva-Rodríguez, G., Cerón-Lizárraga, T., Martínez-Barrera, L. M., Vázquez-Manríquez, M. E., Ríos-Trejo, M. Á., Álvarez-Avitia, M. Á., Hernández‐Pedro, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6452 · Cited by 128
Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance
Lee, T. H., Tun-Kyi, A., Shi, R., Lim, J., Soohoo, C., Finn, G., Balaštík, M., Pastorino, L., Wulf, G. M., Zhou, X. Z., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1818 · Cited by 124
Self-citationProlyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics
Lu, K. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00218-6 · Cited by 123
Self-citationEpigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
Urusova, D. V., Shim, J., Kim, D. J., Jung, S. K., Zykova, T. A., Carper, A., Bode, A. M., & Dong, Z. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0301 · Cited by 122
Nishi, M., Sakai, Y., Akutsu, H., Nagashima, Y., Quinn, G., Masui, S., Kimura, H., Perrem, K., Umezawa, A., Yamamoto, N., et al. (2013) · Oncogene · doi:10.1038/onc.2012.614 · Cited by 121
Suizu, F., Ryo, A., Wulf, G. M., Lim, J., & Lu, K. P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1463-1479.2006 · Cited by 119
Self-citationPin1 has opposite effects on wild-type and P301L tau stability and tauopathy
Lim, J., Balaštík, M., Lee, T. H., Nakamura, K., Liou, Y., Sun, A., Finn, G., Pastorino, L., Lee, V. M. ‐., & Lu, K. P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34308 · Cited by 118
Self-citationDeCensi, A., Robertson, C., Guerrieri‐Gonzaga, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.3797 · Cited by 114
van Drogen, F., Sangfelt, O., Malyukova, A., Matskova, L. V., Yeh, E. S., Means, A. R., & Reed, S. I. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.020 · Cited by 112
Eckerdt, F., Yuan, J., Saxena, K., Martin, B. T., Kappel, S., Lindenau, C., Krämer, A., Naumann, S. C., Daum, S., Fischer, G. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504548200 · Cited by 110
Periyasamy, S., Hinds, T., Shemshedini, L., Shou, W., & Sanchez, E. R. (2010) · Oncogene · doi:10.1038/onc.2009.458 · Cited by 108
Kim, K., Kim, G., Kim, J. Y., Yun, H. J., Lim, S.-C., & Choi, H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu044 · Cited by 108
Sheng, N., Xie, Z., Wang, C., Bai, G., Zhang, K., Zhu, Q., Song, J., Guillemot, F., Chen, Y., Lin, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009244107 · Cited by 107
Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity
Lufei, C., Koh, T. H., Uchida, T., & Cao, X. (2007) · Oncogene · doi:10.1038/sj.onc.1210567 · Cited by 106
Pin1 inhibitors: Pitfalls, progress and cellular pharmacology
Moore, J. D., & Potter, A. J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.088 · Cited by 105
Hepatocellular CarcinomaPreprint
Buendia, M., & Neuveut, C. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021444 · Cited by 105
Prolyl cis/trans isomerase signalling pathways in cancer
Theuerkorn, M., Fischer, G. S., & Schiene‐Fischer, C. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.007 · Cited by 104
Wang, X. J., Xu, B., Mullins, A. B., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja046396m · Cited by 103
Nakano, A., Koinuma, D., Miyazawa, K., Uchida, T., Saitoh, M., Kawabata, M., Hanai, J.-I., Akiyama, H., Abe, M., Miyazono, K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804659200 · Cited by 103
Prolyl Isomerase PIN1 Regulates DNA Double-Strand Break Repair by Counteracting DNA End Resection
Steger, M., Murina, O., Hühn, D., Ferretti, L. P., Walser, R., Hänggi, K., Lafranchi, L., Neugebauer, C., Paliwal, S., Janščák, P., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.03.023 · Cited by 101
Lee, K., Lin, F., Hsu, T., Lin, J., Guo, J.-H., Tsai, C.-H., Lee, Y., Lee, Y., Chen, C., Hsiao, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.001 · Cited by 100
PIN1 promoter polymorphisms are associated with Alzheimer's disease
Segat, L., Pontillo, A., Annoni, G., Trabattoni, D., Vergani, C., Clerici, M., Arosio, B., & Crovella, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.009 · Cited by 100
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
Potter, A. J., Oldfield, V., Nunns, C. L., Fromont, C., Ray, S. C., Northfield, C. J., Bryant, C., Scrace, S., Robinson, D. A., Matossova, N., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.063 · Cited by 99
Chen, C.-H., Li, W., Rukhsana Sultana, A., You, M., Kondo, A., Shahpasand, K., Kim, B. M., Luo, M.-L., Nechama, M., Lin, Y., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.027 · Cited by 96
Self-citationATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1
Hilton, B. A., Li, Z., Musich, P. R., Wang, H., Cartwright, B. M., Serrano, M., Zhou, X. Z., Lu, K. P., & Zou, Y. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.008 · Cited by 95
Self-citationPin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease
Driver, J. A., Zhou, X. Z., & Lu, K. P. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.025 · Cited by 95
Self-citationReineke, E. L., Lam, M. C., Liu, Q., Liu, Y., Stanya, K. J., Chang, K.-S., Means, A. R., & Kao, H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01848-07 · Cited by 95
Liao, Y., Wei, Y., Zhou, X., Yang, J. Y., Dai, C., Chen, Y. J., Agarwal, N., Sarbassov, D. D., Shi, D., Yu, D., et al. (2009) · Oncogene · doi:10.1038/onc.2009.98 · Cited by 94
Self-citationAblain, J., Leiva, M., Pérès, L., Fonsart, J., Anthony, E., & de Thé, H. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122337 · Cited by 94
The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation
Luo, M., Gong, C., Chen, C.-H., Hu, H., Huang, P., Zheng, M., Yao, Y., Wei, S., Wulf, G. M., Lieberman, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.002 · Cited by 91
Self-citationWildemann, D., Erdmann, F., Alvarez, B. H., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060036n · Cited by 90
Ramlau, R., Zatloukal, P., Jassem, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2614 · Cited by 89
Pin1 allows for differential Tau dephosphorylation in neuronal cells
Hamdane, M., Dourlen, P., Bretteville, A., Sambo, A., Ferreira, S., Ando, K., Kerdraon, O., Bégard, S., Geay, L., Lippens, G. M., et al. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.03.006 · Cited by 86
Luo, M.-L., Gong, C., Chen, C.-H., Lee, D. Y., Hu, H., Huang, P., Yao, Y., Guo, W., Reinhardt, F., Wulf, G. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2785 · Cited by 86
Self-citationPin1 modulates RNA polymerase II activity during the transcription cyclePreprint
Xu, Y., & Manley, J. L. (2007) · Genes & Development · doi:10.1101/gad.1592807 · Cited by 85
Yi, P., Wu, R., Sandquist, J. C., Wong, J., Tsai, S. Y., Tsai, M., Means, A. R., & O’Malley, B. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9687-9699.2005 · Cited by 85
Zheng, Y., Yang, W., Xia, Y., Hawke, D. H., Liu, D. X., & Lu, Z. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05547-11 · Cited by 85
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
Budd, G. T., Adamson, P. C., Gupta, M. K., Homayoun, P., Sandstrom, S. K., Murphy, R. F., McLain, D., Tuason, L. J., Peereboom, D. M., Bukowski, R. M., et al. (1998) · PubMed · Cited by 84
SENP1 deSUMOylates and Regulates Pin1 Protein Activity and Cellular Function
Chen, C.-H., Chang, C., Lee, T. H., Luo, M., Huang, P., Liao, P.-H., Wei, S., Li, F., Chen, R., Zhou, X. Z., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4360 · Cited by 84
Self-citationMembrane Permeable Cyclic Peptidyl Inhibitors against Human Peptidylprolyl Isomerase Pin1
Liu, T., Liu, Y., Kao, H., & Pei, D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901778v · Cited by 84
Tun-Kyi, A., Finn, G., Greenwood, A., Nowak, M. A., Lee, T. H., Asara, J. M., Tsokos, G. C., Fitzgerald, K., Israel, E., Li, X., et al. (2011) · Nature Immunology · doi:10.1038/ni.2069 · Cited by 83
Self-citationEck, K., Yuan, L., Duffy, L., Ram, P. T., Ayettey, S., Chen, I., Cohn, C., Reed, J., & Hill, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.357 · Cited by 81
Rajbhandari, P., Finn, G., Solodin, N. M., Singarapu, K. K., Sahu, S. C., Markley, J. L., Kadunc, K., Miner, S. J., Kariagina, A., Haslam, S. Z., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06073-11 · Cited by 79
Self-citationRizzolio, F., Lucchetti, C., Caligiuri, I., Marchesi, I., Caputo, M., Klein–Szanto, A. J., Bagella, L., Castronovo, M., & Giordano, A. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2011.202 · Cited by 75
Prolyl Isomerase Pin1 Regulates Neuronal Differentiation via β-Catenin
Nakamura, K., Kosugi, I., Lee, D. Y., Hafner, A. V., Sinclair, D. A., Ryo, A., & Lu, K. P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05688-11 · Cited by 75
Self-citationMa, S. L., Tang, N. L. S., Tam, C. W. C., Lui, V. W.-C., LAM, L. C. W., Chiu, H. F. K., Driver, J. A., Pastorino, L., & Lu, K. P. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.018 · Cited by 74
Self-citationLam, P. B., Burga, L. N., Wu, B. P., Hofstatter, E. W., Lu, K. P., & Wulf, G. M. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-91 · Cited by 73
Self-citationBrenkman, A. B., de Keizer, P. L. J., van den Broek, N. J. F., van der Groep, P., van Diest, P. J., van der Horst, A., de Vries-Smits, A. M. M., & Burgering, B. M. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1059 · Cited by 73
Rangasamy, V., Mishra, R., Sondarva, G. V., Das, S., Lee, T. H., Bakowska, J. C., Tzivion, G., Malter, J. S., Rana, B., Lu, K. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200804109 · Cited by 72
Self-citationMechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase
Okamoto, K., & Sagata, N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607357104 · Cited by 70
Zheng, J., Koblinski, J. E., Dutson, L. V., Feeney, Y. B., & Clevenger, C. V. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0639 · Cited by 70
Schneider, S. M., Offterdinger, M., Huber, H. P., & Grunt, T. W. (2000) · PubMed · Cited by 70
Pin1 modulates the dephosphorylation of the RNA polymerase II C‐terminal domain by yeast Fcp1
Kops, O., Zhou, X. Z., & Lu, K. P. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02288-3 · Cited by 69
Self-citationLü, J., Hu, Z., Wei, S., Wang, L., Liu, Z., El‐Naggar, A. K., Sturgis, E. M., & Wei, Q. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp171 · Cited by 64
Evidence that the substrate backbone conformation is critical to phosphorylation by p42 MAP kinase
Weiwad, M., Küllertz, G., Schutkowski, M., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01794-4 · Cited by 64
Takahashi, K., Akiyama, H., Shimazaki, K. I., Uchida, C., Akiyama-Okunuki, H., Tomita, M., Fukumoto, M., & Uchida, T. (2006) · Oncogene · doi:10.1038/sj.onc.1210153 · Cited by 63
Li, C., Chang, D. L. F., Yang, Z., Qi, J., Liu, R., He, H., Li, D., & Xiao, Z. J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.468 · Cited by 61
Estey, M. P., Ciano‐Oliveira, C. D., Froese, C. D., Fung, K., Steels, J. D., Litchfield, D. W., & Trimble, W. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474932 · Cited by 59
The Prolyl Isomerase Pin1 Functions in Mitotic Chromosome Condensation
Xu, Y., & Manley, J. L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.020 · Cited by 59
Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT
Stanya, K. J., Liu, Y., Means, A. R., & Kao, H. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806172 · Cited by 59
Obchoei, S., Weakley, S. M., Wongkham, S., Wongkham, C., Sawanyawisuth, K., Yao, Q. C., & Chen, C. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-102 · Cited by 58
A Distinct Role for Pin1 in the Induction and Maintenance of Pluripotency
Nishi, M., Akutsu, H., Masui, S., Kondo, A., Nagashima, Y., Kimura, H., Perrem, K., Shigeri, Y., Toyoda, M., Okayama, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187989 · Cited by 57
Choi, H. J., Kim, J. H., Lim, S., Kim, G., Yun, H. J., & Choi, H. S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13274 · Cited by 56
Pulikkan, J. A., Dengler, V., Zada, A. A. P., Kawasaki, A., Geletu, M., Pasalic, Z., Bohlander, S. K., Ryo, A., Tenen, D. G., & Behre, G. (2010) · Leukemia · doi:10.1038/leu.2010.37 · Cited by 56
PIN1 expression contributes to hepatic carcinogenesis
Pang, R., Lee, T. K., Man, K., Poon, R. T. P., Fan, S., Kwong, Y., & Tse, E. (2006) · The Journal of Pathology · doi:10.1002/path.2024 · Cited by 55
Zhang, X., Zhang, B., Gao, J., Wang, X., & Liu, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478016 · Cited by 55
Spermatogonial Depletion in Adult Pin1-Deficient Mice1
Atchison, F. W., & Means, A. R. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.103.020859 · Cited by 55
Pastorino, L., Sun, A., Lu, P., Zhou, X., Balaštík, M., Finn, G., Wulf, G. M., Lim, J., Li, S., Li, X., et al. (2007) · Nature · doi:10.1038/nature05606 · Cited by 55
Self-citationHellmuth, S., Rata, S., Brown, A., Heidmann, S. K., Novák, B., & Stemmann, O. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.025 · Cited by 54
Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression
Franciosa, G., Diluvio, G., Gaudio, F. D., Giuli, M. V., Palermo, R., Grazioli, P., Campese, A. F., Talora, C., Bellavia, D., d’Amati, G., et al. (2016) · Oncogene · doi:10.1038/onc.2016.5 · Cited by 52
Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCFβtrcp
Bernis, C., Vigneron, S., Burgess, A., Labbé, J., Fesquet, D., Castro, A., & Lorca, T. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400853 · Cited by 50
Lee, N., Choi, H.-K., Shim, J., Kang, K.-W., Dong, Z., & Choi, H. S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp027 · Cited by 48
SCP Phosphatases Suppress Renal Cell Carcinoma by Stabilizing PML and Inhibiting mTOR/HIF Signaling
Lin, Y., Lu, L.-T., Chen, H., Duan, X., Lin, X., Feng, X., Tang, M., & Chen, R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1330 · Cited by 46
The Peptidyl-Prolyl Isomerase Pin1 Regulates Cytokinesis through Cep55
van der Horst, A., & Khanna, K. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0825 · Cited by 45
Péloponèse, J., Yasunaga, J., Kinjo, T., Watashi, K., & Jeang, K. (2009) · Journal of Virology · doi:10.1128/jvi.01824-08 · Cited by 45
Khanal, P., Kim, G., Lim, S., Yun, H., Lee, K. Y., Choi, H., & Choi, H. S. (2013) · The FASEB Journal · doi:10.1096/fj.13-236851 · Cited by 44
Pin1 inhibits PP2A-mediated Rb dephosphorylation in regulation of cell cycle and S-phase DNA damage
Tong, Y., Ying, H., Liu, R., Li, L., Bergholz, J. S., & Xiao, Z.-X. J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.3 · Cited by 43
Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis
Chen, H.-Z., Li, L., Wang, W.-J., Du, X.-D., Wen, Q., He, J., Zhao, B.-X., Li, G.-D., Zhou, W., Xia, Y. F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.463 · Cited by 42
The peptidyl–prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor α stability
Brondani, V., Schefer, Q., Hamy, F., & Klimkait, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.130 · Cited by 41
Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer
Tsang, Y.-H. N., Wu, X.-W., Lim, J.-S., Ong, C. W., Salto‐Tellez, M., Ito, K., Ito, Y., & Chen, L.-F. (2012) · Oncogene · doi:10.1038/onc.2012.178 · Cited by 40
Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc
D’Artista, L., Bisso, A., Piontini, A., Doni, M., Verrecchia, A., Kress, T. R., Morelli, M. J., Sal, G. D., Amati, B. B., & Campaner, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7846 · Cited by 40
Lee, Y., Que, J., Chen, Y., Lin, J., Liou, Y.-C., Liao, P.-C., Liu, Y., Lee, K., Lin, L.-C., Hsiao, M., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.121368 · Cited by 37
A critical step for JNK activation: isomerization by the prolyl isomerase Pin1
Park, J. E., Lee, J. A., Park, S., Lee, D. H., Kim, S. J., Kim, H.-J., Uchida, C., Uchida, T., Park, B. C., & Cho, S. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.82 · Cited by 36
Jeong, S., Ryo, A., & Yamamoto, N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.024 · Cited by 36
Khanal, P., Namgoong, G. M., Kang, B. S., Woo, E., & Choi, H. S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0560 · Cited by 36
COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer
Kim, G., Khanal, P., Kim, J. Y., Yun, H., Lim, S., Shim, J., & Choi, H. S. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22112 · Cited by 35
Pleiotropic roles in cancer biology for multifaceted proteins FKBPs
Romano, S., D’Angelillo, A., & Romano, M. F. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.004 · Cited by 35
Hwang, Y., Yang, C.-H., Lin, C.-H., Ch'ang, H.-J., Chang, V. H. S., & Yu, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.010 · Cited by 33
van Tiel, C. M., Kurakula, K., Koenis, D. S., van der Wal, E., & de Vries, C. J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.06.030 · Cited by 32
Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships
Mantovani, F., Zannini, A., Rustighi, A., & Sal, G. D. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.013 · Cited by 31
The rs2233678 Polymorphism in PIN1 Promoter Region Reduced Cancer Risk: A Meta-Analysis
Li, Q., Zhao, D. H., Lin, Y., Jia, X., Li, Q., Jiang, H., Wang, L., & Gao, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068148 · Cited by 31
Androgen receptor serine 81 mediates Pin1 interaction and activity
Montagna, R. L., Caligiuri, I., Maranta, P., Lucchetti, C., Esposito, L., Paggi, M. G., Toffoli, G., Rizzolio, F., & Giordano, A. (2012) · Cell Cycle · doi:10.4161/cc.21730 · Cited by 30
Cho, Y. S., Park, S. Y., Kim, D. J., Lee, S.-H., Woo, K.-M., Lee, K., Lee, Y.-J., Cho, Y., & Shim, J. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1322-y · Cited by 27
Sakuma, Y., Nishikiori, H., Hirai, S., Yamaguchi, M., Yamada, G., Watanabe, A., Hasegawa, T., Kojima, T., Niki, T., & Takahashi, H. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.155 · Cited by 27
PINA Is Essential for Growth and Positively Influences NIMA Function in Aspergillus nidulans
Joseph, J. D., Daigle, S. N., & Means, A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405415200 · Cited by 25
Williams, P. D., Owens, C. R., Dziegielewski, J., Moskaluk, C. A., Read, P. W., Larner, J. M., Story, M. D., Brock, W. A., Amundson, S. A., Lee, J. K., et al. (2011) · Neoplasia · doi:10.1593/neo.111398 · Cited by 24
Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α
Rajbhandari, P., Ozers, M. S., Solodin, N. M., Warren, C. L., & Alarid, E. T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.621698 · Cited by 21
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma
Teng, B. L., Hacker, K. E., Chen, S., Means, A. R., & Rathmell, W. K. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.06.002 · Cited by 20
Guito, J. C., Gavina, A., Palmeri, D., & Lukac, D. M. (2013) · Journal of Virology · doi:10.1128/jvi.02877-13 · Cited by 19
Khanal, P., Kim, G., Yun, H. J., Cho, H., & Choi, H. S. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21920 · Cited by 17
Jain, P., Kantarjian, H., Estey, E., Pierce, S., Cortes, J., Lopez-Berestein, G., & Ravandi, F. (2014) · Clinical Lymphoma Myeloma and Leukemia · doi:10.1016/j.clml.2013.08.004 · Cited by 15
Pin1: A molecular orchestrator in the heart
Hariharan, N., & Sussman, M. A. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.05.010 · Cited by 13
Jo, A., Yun, H. J., Kim, J. Y., Lim, S., Choi, H. J., Kang, B. S., Choi, B., & Choi, H. S. (2015) · PubMed · Cited by 11
Cited by
The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
Dhanasekaran, R., Deutzmann, A., Mahauad-Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00549-2 · Cited by 986
Kozono, S., Lin, Y.-M., Seo, H.-S., Pinch, B., Lian, X., Qiu, C., Herbert, M. K., Chen, C.-H., Tan, L., Gao, Z. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05402-2 · Cited by 168
Self-citationNapoletano, F., Ferrari Bravo, G., Voto, I. A. P., Santin, A., Celora, L., Campaner, E., Dezi, C., Bertossi, A., Valentino, E., Santorsola, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109694 · Cited by 36
Musich, P. R., Li, Z., & Zou, Y. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-56017-5_4 · Cited by 23
Metadata
- Authors
- Zhou, X. Z., & Lu, K. P.
- Venue
- Nature Reviews Cancer
- Published
- 2016-06-03
- Volume
- 16
- Issue
- 7
- Pages
- 463-478
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2416176918
- Cited by
- 266
- References
- 195
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.